Amid ongoing investigations and the indictment and guilty plea of former Del. Cheryl D. Glenn (D-Baltimore City), House lawmakers received an update Wednesday from the leaders of the Natalie M. LaPrade Medical Cannabis Commission.
During the briefing before the House Health and Government Operations Committee, Executive Director William Tilburg addressed the series of problems that the commission has faced in the last few months — notably licensure application delays and Glenn’s charges.
Glenn resigned in December ahead of bribery and federal wire fraud charges raised against her for pushing cannabis legislation for personal economic gain. She pleaded guilty during an arraignment held Wednesday afternoon in Baltimore.
